JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258940

Human LAPTM4A knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

LAPTM4A KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 7 bp deletion in exon 1.

View Alternative Names

Golgi 4-transmembrane-spanning transporter MTP, HUMORF13, KIAA0108, LAP4A_HUMAN, LAPTM4, LAPTM4A, Lysosomal associated protein transmembrane 4 alpha, Lysosomal protein transmembrane 4 alpha, Lysosomal-associated transmembrane protein 4A, MBNT, MTRP, Membrane nucleoside transporter

1 Images
Sanger Sequencing - Human LAPTM4A knockout HEK-293T cell lysate (AB258940)
  • Sanger seq

Unknown

Sanger Sequencing - Human LAPTM4A knockout HEK-293T cell lysate (AB258940)

Homozygous : 7 bp deletion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 7 bp deletion in exon 1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258940-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human LAPTM4A knockout HEK293T cell lysate", "number":"AB258940-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258940-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LAPTM4A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LAPTM4A also known as Lysosomal-associated transmembrane protein 4 alpha is a protein involved in intracellular trafficking. It has a molecular weight of approximately 28 kDa. LAPTM4A consists of four predicted transmembrane domains and expresses in various tissues with high levels in the spleen kidney and liver. It plays a role in endosomal and lysosomal pathways influencing cellular processes like nutrient transport and recycling.
Biological function summary

This protein contributes to cell comprehension by facilitating lysosomal function and maintaining cellular homeostasis. LAPTM4A participates in the regulation of proliferation and survival often forming a complex with other lysosomal proteins for transmitting signals related to these processes. It impacts cellular signaling pathways by interacting with certain membrane receptors and transporting them to lysosomes for degradation or recycling.

Pathways

LAPTM4A is an integral part of endocytic and vesicular transport pathways. It influences receptor-mediated endocytosis that directs cell surface proteins to lysosomes for degradation or recycling. In these pathways LAPTM4A interacts with other proteins like c-MET a receptor tyrosine kinase that plays a part in signal transduction processes linked to cell growth.

Mutations or alterations in LAPTM4A levels can connect to cancer and psychiatric disorders like schizophrenia. The protein's interaction with c-MET has identified its role in tumor progression where abnormal c-MET signaling contributes to cancerous growth. Furthermore alterations in LAPTM4A can affect neurotransmitter systems associating the protein with schizophrenia's pathophysiology.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com